Fluor Completes Bayer’s First Global Cell Therapy Launch Facility in Berkeley, California
- Fluor Corporation has completed construction of Bayer's first global Cell Therapy Launch Facility in Berkeley, California.
- The state-of-the-art facility will be used to produce cell therapies for various medical needs.
- Fluor's innovative plant layout and modularized construction approach allowed for safe and efficient construction.
- Fluor also completed construction of Bayer's Single Use Technology biopharmaceutical manufacturing Cell Culture Technology Center in 2021.
- None.
Second new facility built by Fluor on Bayer’s Biotech campus in
Bayer's first global Cell Therapy Launch Facility was recently completed by Fluor Corporation. The new, state-of-the-art biopharmaceutical development and manufacturing facility will be used to produce cell therapies for neurological degenerative disorders, cardiovascular disease and other unmet medical needs. (Photo: Business Wire)
“Fluor’s innovative plant layout and modularized construction approach allowed this facility to be built safely and with capital efficiency,” said Richard Meserole, president of Fluor’s Advanced Technologies & Life Sciences business line. “The project was phased to allow start-up activities to commence as needed to support production timeline.”
The new state-of-the-art biopharmaceutical development and manufacturing facility will be used to produce cell therapies for neurological degenerative disorders, cardiovascular disease and other unmet medical needs.
Fluor’s scope of work included the engineering, procurement, construction management, commissioning, qualification and validation for the facility.
Fluor also completed construction of Bayer’s state-of-the-art Single Use Technology biopharmaceutical manufacturing Cell Culture Technology Center (CCTC) in 2021. The CCTC supports Bayer’s teams producing multiple biologic therapies.
About Fluor Corporation
Fluor Corporation (NYSE: FLR) is building a better world by applying world-class expertise to solve its clients’ greatest challenges. Fluor’s 40,000 employees provide professional and technical solutions that deliver safe, well-executed, capital-efficient projects to clients around the world. Fluor had revenue of
#ATLS
View source version on businesswire.com: https://www.businesswire.com/news/home/20231018153130/en/
Brett Turner
Media Relations
864.281.6976
Jason Landkamer
Investor Relations
469.398.7222
Source: Fluor Corporation
FAQ
What is the purpose of Bayer's Cell Therapy Launch Facility?
Who completed the construction of the facility?
What other facility did Fluor Corporation complete for Bayer?
